Aurora's new genetics licensing business unit, focused on the scientific discovery and commercial advancement of novel cannabis cultivars, will be called Occo.
"With the largest catalogue of high-quality genetics available for licensing in Canada, Occo is aptly positioned to reach its goals of further developing the scientific understanding of cannabis, commercializing high-quality products, providing value for cannabis growers, and helping to realize the full potential of the cannabis plant," the Aurora team states.
Charles Pick, Senior Vice President of Science & Innovation at Aurora Cannabis: "Occo already has more than 30 high-quality cultivars, not available anywhere else on the market, that are ready for immediate trial and exclusive licensing."
Occo will be based out of Aurora's Coast research and development hub. The team includes experts in genomics, biotechnology, pathology, tissue culture, analytics and testing, medical affairs, and product development.
Aurora